Bristol-Myers buys rights to fibrosis drug for up to $1.25 bln
August 31, 2015 at 08:42 AM EDT
Aug 31 (Reuters) - Drugmaker Bristol-Myers Squibb said it would buy the worldwide rights to a mid-stage fibrosis drug from privately held Promedior Inc for up to $1.25 billion.
